UHRF2 has also been reported to affect certain phenotypes of tumor cells through DNA demethylation, the ErbB3/Ras/Raf signaling pathway, and the Wnt/β-catenin signaling pathway [64–69]. Here, ERBB3 is linked to neoplasm.